An anti-COVID-19 therapeutic application of the drug 2-DG has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a DRDO lab along with DRL. Defence Minister Rajnath Singh formally handed over the drug to Health Minister Dr Harsh Vardhan.
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence, DRDO has said earlier adding, “Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.”
You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.
Here are the latest updates:
National
Former IMA president K.K. Aggarwal dies of COVID-19
Padma Shree awardee and former national president of the Indian Medical Association K.K. Aggarwal (62) passed away due to COVID-related complications at All India Institute of Medical Sciences, Delhi on Monday,…